|
Mar 21
|
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 2
|
Is Evolus, Inc. (EOLS) the Best Small Cap Pharma Stock to Buy Now?
|
|
Feb 27
|
Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
|
|
Feb 20
|
Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
|
|
Feb 18
|
Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025
|